vblrx.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	VBL
Description	Targeted Therapies Broad VBL Therapeutics is a publicly traded (NASDAQ: VBLT), clinical stage biotechnology company committed to the discovery, development and commercialization of next-generation, targeted medicines for difficult-to-treat medical
Keywords	N/A

Server Information

WebSite	vblrx.com
Host IP	185.201.148.15
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

whitenoiseproduction.com

yourtemplatefinder.com

yumvs.com

zerostressfunding.com

guseingasanov.pro

vblrx.com Valuation

US$14,069,614

Last updated: 2023-04-30 14:20:02

vblrx.com has Semrush global rank of 752,281. vblrx.com has an estimated worth of US$ 14,069,614, based on its estimated Ads revenue. vblrx.com receives approximately 1,623,417 unique visitors each day. Its web server is located in -, with IP address 185.201.148.15. According to SiteAdvisor, vblrx.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$14,069,614
Daily Ads Revenue	US$12,988
Monthly Ads Revenue	US$389,621
Yearly Ads Revenue	US$4,675,441
Daily Unique Visitors	108,228
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
vblrx.com.	A	297	IP: 185.201.148.15
vblrx.com.	NS	300	NS Record: ns2.bezeqint.net.
vblrx.com.	NS	300	NS Record: ns3.bezeqint.net.
vblrx.com.	NS	300	NS Record: ns1.bezeqint.net.
vblrx.com.	MX	300	MX Record: 0 vblrx-com.mail.protection.outlook.com.
vblrx.com.	TXT	300	TXT Record: piIus9gpYhUYTyfi/HJUYBI7hxkxIEjOriBMc6JK2CvIIWyEcOSUU7XJ0hlP/ax/RH3rl4N8F5PGALW1vq464Q==
vblrx.com.	TXT	300	TXT Record: MS=ms55228012
vblrx.com.	TXT	300	TXT Record: v=spf1 a a: ip4:62.219.147.167 include:v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-04-30 14:20:02

menu Menu Search Targeted Therapies Broad Potential We are focused on developing targeted therapies for We are focused on developing targeted therapies for immune-inflammatory diseases immune-inflammatory diseases Our lead candidate VB-601 has potential to be broadly applicable across both prevalent & rare inflammatory indications. Our lead candidate VB-601 has potential to be broadly applicable across both prevalent & rare inflammatory indications. Our expertise in human biology led to the development of our proprietary monocyte targeting technology (MTT), which is designed in a specific way to limit chronic inflammation. Monocyte Targeting Technology About Us Our Technology Investor Relations Contact Us VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for immune-inflammatory diseases. VBL’s lead immunology product candidate VB-601 is a targeted antibody for immune-inflammatory applications expected to enter Phase 1 in the first quarter of 2023, that has shown

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 23 Oct 2021 08:58:11 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: http://www.vblrx.com/

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 23 Oct 2021 08:58:12 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://www.vblrx.com/

HTTP/2 200 
server: nginx
date: Sat, 23 Oct 2021 08:58:14 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel=shortlink

vblrx.com Whois Information

Domain Name: VBLRX.COM
Registry Domain ID: 1574218398_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-10-28T08:13:52Z
Creation Date: 2009-11-01T07:02:40Z
Registry Expiry Date: 2022-11-01T06:02:40Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.BEZEQINT.NET
Name Server: NS2.BEZEQINT.NET
Name Server: NS3.BEZEQINT.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T20:26:08Z <<<

vblrx.com valuation and analysis